Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation-Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology.

Background. The Chinese patent drug Yinzhihuang granule (YZHG) is used to treat hepatitis B. This research is aimed at exploring the multicomponent synergistic mechanism of YZHG in the treatment of inflammation-cancer transformation of hepar and at providing new evidence and insights for its clinica...

Descripción completa

Detalles Bibliográficos

Publicado en:	BioMed Research International pp. 1 - 14
Autores principales:	Zhang, Jingyuan, Huang, Zhihong, Liu, Xinkui, Wu, Chao, Zhou, Wei, Ye, Peizhi, Stalin, Antony, Lu, Shan, Tan, Yingying, Wu, Zhishan, Fan, Xiaotian, Zhang, Xiaomeng, Wang, Miaomiao, Li, Bingbing, Cheng, Guoliang, Mou, Yanfang, Wu, Jiarui
Formato:	pictorial research tables/charts Journal Article
Publicado:	Wiley-Blackwell 3/18/2022
Acceso en línea:	Ver este registro en EBSCOhost